title: Mutations for the people.
abstract: Similar cancer types may nevertheless differ widely in the genetic mutations they carry. In this Closeup, Kristensen and Borresen-Dale discuss how identifying these mutations can define which therapy is most likely to succeed in eliminating the cancerous cells and how the methodology developed by Dias-Santagata et al and described in this issue, is an important step in making mutation screening a reality in the clinical practice worldwide.
authors.affiliation: Institute for Cancer Research, Oslo, Norway. v.n.kristensen@medisin.uio.no
authors.forename: Vessela
authors.initials: V
authors.lastname: Kristensen
authors.forename: Anne-Lise
authors.initials: AL
authors.lastname: Borresen-Dale
mesh_terms: D004252:DNA Mutational Analysis; D005838:Genotype; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy
references.citation: Nature. 2007 Mar 8;446(7132):153-8
references.pmid: 17344846
references.citation: Nature. 2009 Dec 24;462(7276):1005-10
references.pmid: 20033038
references.citation: Nucleic Acids Res. 2010 Jan;38(Database issue):D652-7
references.pmid: 19906727
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13081-6
references.pmid: 18723673
references.citation: Nature. 2010 Jan 14;463(7278):184-90
references.pmid: 20016488
references.citation: Sci Transl Med. 2010 Feb 24;2(20):20ra14
references.pmid: 20371490
references.citation: Nature. 2010 Jan 21;463(7279):360-3
references.pmid: 20054297